Table 1.
Affected organ/system | Complication | Proposed mechanism of action | References |
---|---|---|---|
Immune | ↑ HIV disease progression | ↑ CD4 and CD8 T-cell activation, leading to ↑ immune dysfunction and cytokine production, enhanced HIV and HCV production, and ↓ T-cell counts | [24••, 25, 26] |
HCV-induced ↑ CD4 T-cell apoptosis, leading to severe immunodeficiency | [27] | ||
HCV-induced ↓ CD4 recovery post-HAART | [28] | ||
↑Cryoglobulinemia | ↑ Cryoglobulin production by activated B cells | [53] | |
↓ CRP production in liver | Unknown | [54] | |
Liver | ↑ Steatosis | HIV-related mitochondrial translocation (↑LPS)-induced immune activation | [16, 18, 26, 42] |
↑ Fibrosis | ↑ Activation of CD4 and CD8 T cells | [26] | |
↑ Cirrhosis | ↑ Levels of cytokines (eg, IL-4, IL-5, IL-13, TGF-β, IFN-γ and TNF-α ) and chemokines (eg, IP-10 and IL-8) | [17, 18] | |
↑ ESLD | HIV-induced ↓ HCV-specific CD4 and CD8 T-cell responses | [16, 17] | |
↑ HCC | ↑ Levels of cytotoxic CD8 T cells in liver | [39, 40] | |
↑ Activation of HSC | [18, 19, 43] | ||
↑ Apoptosis of hepatocytes and HSC, mediated by TRAIL | [16–19, 44] | ||
↑ Collagen synthesis by HIV-infected HSC | [43] | ||
↑ HSC production of collagen by HIV-infected Kupffer cells | [16] | ||
Insulin resistance–associated hyperinsulinemia and hyperglycemia stimulate HSC to ↑ connective tissue growth factor and extracellular matrix | [45, 46] | ||
Liver/metabolic | Diabetes mellitus | Unknown | [68] |
Insulin resistance | Unknown | [46] | |
Cardiovascular | HIV- and HCV-associated chronic inflammation leads to endothelial dysfunction, causing ↑ sCAMS | [59, 60] | |
Hematologic | Thrombocytopenia | Sequestration of platelets in cirrhosis and portal hypertension | [55] |
↓ Production of thrombopoietin in advanced liver disease | [55] | ||
Kidney | Proteinuria | Unknown | [56] |
Acute interstitial nephritis | Unknown | [58] | |
Acute tubular necrosis | |||
MPGN | Stimulation of B cells to ↑cryoglobulin production and deposits in renal vessels | [53, 56–58] | |
Acute renal failure | |||
Chronic kidney disease | |||
Gastrointestinal | Mitochondrial translocation | HIV-inducted ↑gut permeability and depletion of CD4 cells from gut-associated lymphoid tissue | [16] |
Central/peripheral nervous | Neurocognitive syndromes | HIV and HCV replication in brain | [61] |
Peripheral neuropathy syndromes | HCV core protein activates glia and ↑HIV-associated neurotoxicity | [62] | |
LPS-induced monocyte activation and ↑HIV-associated dementia | [65] | ||
Bone | Osteoporosis | ↓ Bone mass in chronic liver disease | [70] |
Osteonecrosis |
CRP C-reactive protein; ESLD end-stage liver disease; HCC hepatocellular carcinoma; HSC hepatic stellate cells; LEE liver enzyme elevations; LPS lipopolysaccharides; MPGN membranoproliferative glomerulonephritis; sCAMS, soluble cellular adhesion molecules; TRAIL, tumor necrosis factor–related apoptosis-inducing ligand